Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.37 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6724434 | 0.90 | TACR1 (0.38) | TACR1MEN1KMT2ASMN1; SMN2PGR | |
| SCHEMBL6723411 | 0.89 | PTPN1 (0.42) | TACR1MEN1KMT2ASMN1; SMN2PGR | |
| SCHEMBL6724506 | 0.89 | TACR1 (0.38) | TACR1MEN1KMT2ASMN1; SMN2PGR | |
| SCHEMBL27498154 | 0.88 | PTPN1 (0.41) | TACR1MEN1KMT2ASMN1; SMN2HTR7 | |
| SCHEMBL6723948 | 0.87 | MEN1 (0.45) | TACR1MEN1KMT2ASMN1; SMN2BACE1 | |
| SCHEMBL6723970 | 0.86 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2HTR7 | |
| SCHEMBL13826147 | 0.86 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2HTR7 | |
| SCHEMBL6723582 | 0.86 | CHKA (0.41) | TACR1MEN1KMT2ASMN1; SMN2HTR7 | |
| SCHEMBL6723824 | 0.86 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2HTR7 | |
| SCHEMBL6723985 | 0.86 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1696709-B1 | ORGANO-ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | NIPPON STEEL CHEMICAL CO (JP) | 2012-10-24 | — | — | EP | disclosed |
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | disclosed |
| US-7629059-B2 | Organo-electronic functional material and use thereof | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-20090066222-A1 | Organic electronic functional material and use thereof | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| EP-1826837-A1 | ORGANIC ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | Bando Chemical Industries, Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7196224-B2 | 1,3,5-tris(arylamino)benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20070066848-A1 | Organo-electronic functional material and use thereof | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1696709-A1 | ORGANO-ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | Bando Chemical Industries, Ltd. (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066848-A1 | Organo-electronic functional material and use thereof | SLCO2A1, SLCO2B1, KCNN2 | TACR1 3279/4885MEN1 3240/4885KMT2A 3915/4885 |
| US-20090066222-A1 | Organic electronic functional material and use thereof | EFNA1, EPB41, ETFB | TACR1 3217/4885MEN1 3483/4885KMT2A 2543/4885 |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | HSPA4L, HSPA1A, GAPVD1 | TACR1 4593/4885MEN1 4488/4885KMT2A 942/4885 |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | AHR, MYB, NAP1L4 | TACR1 3544/4885MEN1 4676/4885KMT2A 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.